[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346550-105":59,"doc-detail-346550-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ubiquitination-driven-reprogramming-of-proteostasis-in-metastasis-perspective","Ubiquitination-Driven Reprogramming of Proteostasis in Metastasis - Perspective","","Metastasis drives cancer mortality by forcing rapid proteome remodeling under stress, creating urgent demands on proteostasis. The work identifies a non-canonical, metastasis-promoting ubiquitination pathway centered on DCAF12, a Cullin 4–RING substrate receptor. DCAF12 performs non-degradative ubiquitination of TRiC/CCT subunits, allosterically enhancing chaperonin assembly, stability, and folding capacity to support pro-metastatic proteins. The DCAF12–TRiC/CCT axis is proposed as a therapeutic target and as a basis for a “proteostatic stress creation” paradigm, including DCAF12 interaction inhibitors and state-selective degraders.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ubiquitination-driven-reprogramming-of-proteostasis-in-metastasis-perspective/346550/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ubiquitination-driven-reprogramming-of-proteostasis-in-metastasis-perspective/346550.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is proteostasis a critical challenge during metastasis?","Question",{"text":113,"@type":114},"Metastatic progression requires continuous adaptation to fluctuating microenvironments and rapid proteome remodeling. This adaptation depends on proteostasis to balance protein synthesis, folding, trafficking, and degradation to meet stage-specific needs.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does DCAF12 play in the DCAF12–TRiC/CCT axis?",{"text":118,"@type":114},"DCAF12 mediates non-degradative ubiquitination of TRiC/CCT chaperonin subunits via K63- or K27-linked chains. This ubiquitination allosterically activates the chaperonin by increasing assembly, stability, and folding capacity.",{"name":120,"@type":111,"acceptedAnswer":121},"How does DCAF12-dependent ubiquitination support metastatic cell behavior?",{"text":122,"@type":114},"Activated TRiC/CCT improves folding and stabilization of diverse pro-metastatic proteins, including clients tied to motility, cell cycle control, and oncogenic signaling. Co-opting this axis enables a regulatory node that amplifies multiple metastatic capabilities.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346550,1790617745,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Advanced Science    \n[www.advancedscience.com](www.advancedscience.com)  \n PERSPECTIVE   \nUbiquitination-Driven Reprogramming of Proteostasis in Metastasis  \nDongping Wei1   Jiayan Chen2  Yaping Xu3  \n1Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China  2 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China  3 Department of Radiation Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China  \nCorrespondence: Dongping Wei ([weidongping2022@wzm.edu.cn](weidongping2022@wzm.edu.cn))  Jiayan Chen (chenjiayan@fudan.edu.cn)  Yaping Xu (1800515@tongji.edu.cn)  \nReceived: 3 November 2025  Revised: 14 January 2026  Accepted: 15 January 2026  \nKeywords: DCAF12 | metastasis | proteostasis | TRiC/CCT | ubiquitination  \nABSTRACT  \nMetastasis, the leading cause of cancer-related mortality, poses a fundamental proteostatic challenge, requiring rapid and precise proteome remodeling in response to stress. While ubiquitination is linked to protein degradation, our recent work uncovered a non-canonical, metastasis-promoting mechanism centered on DCAF12, a substrate receptor of the Cullin 4–RING ubiquitin ligase complex. DCAF12 mediates non-degradative ubiquitination of TRiC/CCT chaperonin subunits, allosterically activating the chaperonin to enhance its assembly, stability, and folding capacity. This ubiquitination-dependent activation circuit enables metastatic cells to efficiently fold and stabilize diverse pro-metastatic proteins, thereby facilitating dynamic proteomereprogramming. Herein, we present the DCAF12–TRiC/CCT axis as a central regulatory component of this adaptive response, explore its evolutionary basis, and propose DCAF12 as a prototype for a broader class of “DCAFome” regulators of chaperone function. This mechanistic understanding establishes a direct rationale for therapeutically targeting this axis to disrupt adaptive proteostasis. Moreover, we outline a therapeutic paradigm termed “proteostatic stress creation.” This framework encompasses a spectrum of strategies, from precision protein–protein interaction inhibitors to state-selective degraders of DCAF12 or its ubiquitinated chaperonin subunits. These approaches can potentially disrupt the DCAF12–TRiC/CCT axis, thereby undermining the proteostatic resilience that sustains advanced cancers.  \n1  Non-Degradative Ubiquitination Directs Metastatic Adaptation  \nCancer metastasis is a complex, multistep process that encompasses tumor cell detachment, local invasion, intravasation, circulatory survival, extravasation, and colonization of distant tissues [1, 2] . Progression through these stages requires tumor cells to continuously adapt to fluctuating microenvironmentsand dynamically reprogram their behavior [2, 3] . While transcriptional reprogramming initiates these adaptations, their rapid execution critically depends on the proteostasis network, which maintains a delicate balance among protein synthesis, folding,  \ntrafficking, and degradation to meet stage-specific proteostatic demands [3–6] .  \nMolecular chaperones and the ubiquitin-proteasome system (UPS) are the central pillars of proteostatic regulation [7, 8] . Conventional models often oversimplify the interplay between these two systems, portraying the proteasome primarily as a disposal unit—a passive downstream effector of chaperone activity formisfolded proteins [8, 9] . However, this degradation-centric view has recently been revised based on the growing consensus that ubiquitination is a versatile and multifaceted post-translational modification, directly modulating protein activity, stability, and  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH  \nAdvanced Science","cbCaigeaOuByze3z","https://ap.wps.com/l/cbCaigeaOuByze3z","pdf",1747824,"English","# Non-Degradative Ubiquitination Directs Metastatic Adaptation\n## Proteostasis demands across metastatic stages\n## Ubiquitination as a signaling and regulatory mechanism\n# From DCAF12 to the DCAFome: An Expansive Chaperone Regulatory Network","[{\"question\":\"Why is proteostasis a critical challenge during metastasis?\",\"answer\":\"Metastatic progression requires continuous adaptation to fluctuating microenvironments and rapid proteome remodeling. This adaptation depends on proteostasis to balance protein synthesis, folding, trafficking, and degradation to meet stage-specific needs.\"},{\"question\":\"What role does DCAF12 play in the DCAF12–TRiC/CCT axis?\",\"answer\":\"DCAF12 mediates non-degradative ubiquitination of TRiC/CCT chaperonin subunits via K63- or K27-linked chains. This ubiquitination allosterically activates the chaperonin by increasing assembly, stability, and folding capacity.\"},{\"question\":\"How does DCAF12-dependent ubiquitination support metastatic cell behavior?\",\"answer\":\"Activated TRiC/CCT improves folding and stabilization of diverse pro-metastatic proteins, including clients tied to motility, cell cycle control, and oncogenic signaling. Co-opting this axis enables a regulatory node that amplifies multiple metastatic capabilities.\"}]","Ubiquitination-Driven Reprogramming of Proteostasis in Metastasis - Perspective | PDF",1790061945,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59afbedba5b5550a55699c5d16503502.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aaa73c466a7b98438bf0b68d65d7735a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfad7d4849c3309f1a02d795905296ce.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16d08296a24a73de51498e8687f909b7.webp",980,1287]